We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Ultracold Freezer May Replace Liquid Nitrogen Cryopreservation Systems

By LabMedica International staff writers
Posted on 03 Oct 2011
Print article
Image: The MDF-C2156VAN freezer (Photo courtesy of Sanyo).
Image: The MDF-C2156VAN freezer (Photo courtesy of Sanyo).
A new generation of ultra-cold freezers may replace liquid nitrogen storage tanks as the method of choice for long-term preservation of viable cells, tissues, and other sensitive biological materials.

The SANYO (Etten-Leur, The Netherlands) MDF-C2156VAN freezer provides a stable and uniform environment that maintains a constant -150 °C. As this low temperature is below the recrystallization point of water, the SANYO MDF-C2156VAN addresses the long-term storage requirements associated with stem cell research and cell therapy, regenerative medicine, biomedical research, and tissue and cell banks.

The new line of freezers incorporates Sanyo’s proprietary VIP PLUS insulation panels, which reduce the wall thickness from 175 mm to 135 mm. This allows for up to 25% more storage capacity compared with a conventionally insulated freezer without increasing the footprint. The resulting capacity of 231 liters will accommodate up to 14,000 two-milliliter cryostorage tubes.

Complementing the benefits of VIP PLUS insulation, a double lid gasket helps maintain internal temperature stability by preventing cold air loss. The results are lower running costs, greater ease of use and accessibility to stored samples, and no risk of contamination from liquid nitrogen.

The internal temperature is accurately controlled and monitored by an advanced microprocessor controller and specially designed graphic display. As a safety feature to guard against power outages, the freezer is equipped with a liquid nitrogen back-up system as standard, which allows connection to a separate supply vessel.

The MDF-C2156VAN freezer is a worthy addition to Sanyo’s catalog of ultra-low temperature freezers, cryogenic freezers, pharmaceutical and medical refrigerators, cell culture incubators, plant growth chambers, and portable autoclaves.

Related Links:

SANYO


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.